NVIDIA
NVDA
Tesla
TSLA
Intel
INTC
Disney
DIS
Micron Technology
MU
US Stock MarketDetailed Quotes
DYN Dyne Therapeutics
- 13.610
- +0.440+3.34%
Close Feb 28 16:00 ET
- 13.610
- 0.0000.00%
Post 16:19 ET
1.54BMarket Cap-4.04P/E (TTM)
13.670High12.870Low1.76MVolume13.100Open13.170Pre Close23.70MTurnover2.17%Turnover RatioLossP/E (Static)113.12MShares47.45052wk High2.44P/B1.11BFloat Cap12.87052wk Low--Dividend TTM81.41MShs Float47.450Historical High--Div YieldTTM6.07%Amplitude4.300Historical Low13.448Avg Price1Lot Size
About Dyne Therapeutics Company
Dyne Therapeutics Inc is a clinical-stage neuromuscular disease company focused on discovering and advancing life-transforming therapeutics for people living with genetically driven neuromuscular diseases. Its FORCE platform develops targeted therapeutics that are designed to overcome limitations in delivery to muscle tissue and the central nervous system, or CNS. Its FORCE platform therapeutics consist of a payload that is rationally designed to target the genetic basis of the disease are seeking to treat, a linker, and an antigen-binding fragment, that attaches to the payload using the linker. Its Pipeline includes DYNE-101, DYNE-251, DYNE-302, and DYNE-401.
Company Profile
SymbolDYN
Company NameDyne Therapeutics
Listing DateSep 17, 2020
Issue Price19.00
Founded2017
CEOMr. John G. Cox
MarketNASDAQ
Employees191
Fiscal Year Ends12-31
Address830 Winter Street
CityWaltham
ProvinceMassachusetts
CountryUnited States of America
Zip Code02451
Phone1-781-786-8230
Websitehttp://www.dyne-tx.com
Company Executives
- Name
- Position
- Salary
- John G. Cox
- Director, President and Chief Executive Officer
- --
- Dr. Oxana Beskrovnaya, PhD
- Chief Scientific Officer
- --
- Wildon Farwell, M.D.,M.P.H.
- Chief Medical Officer
- --
- Richard William Scalzo
- Senior Vice President, Head of Finance and Administration, Principal Financial and Accounting Officer
- --
- Jason P. Rhodes
- Chairman of the Board
- 283.17K
- David Charles Lubner, C.P.A.,M.S.
- Independent Director
- 264.17K
- Dr. Catherine Stehman-Breen, M.D.
- Independent Director
- 253.92K
- Dr. Carlo Incerti
- Independent Director
- 250.17K
- Edward M. Hurwitz, J.D.
- Independent Director
- 250.17K
- Dirk Kersten
- Independent Director
- 262.67K
Trending Stocks
U.S Tech Companies U.S Tech Companies
U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data. U.S leading technology companies with strong market presence, influential in their industries, and notable for robust innovation and profitability. Information is provided by Futu and is a non-exhaustive list of all thematic stocks for reference purposes only.
This section presents the top 5 stocks in U.S Tech Companies, ranked from highest to lowest based on real-time market data.